肝硬化中的凝血因子XI不能预测血栓性并发症和肝脏衰减补偿
Alberto Zanetto1, Elena Campello2, Luca Spiezia2
1Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.
概括
因子XI (FXI) 水平随着肝硬化严重程度的下降而下降,并不能预测血栓形成或出血. 低FXI与不良结果无关,这表明FXI抑制剂可能对肝硬化患者安全.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血栓形成研究研究
- 凝血因子研究 凝血因子研究
背景情况:
- 因素XI (FXI) 与非肝病患者的血栓形成有关.
- 在肝硬化中,FXI的作用和预后意义尚不清楚.
- 在肝硬化中了解FXI对于管理血栓和出血风险至关重要.
研究的目的:
- 为了研究肝硬化中的FXI变化.
- 为了确定FXI与门静脉血栓症 (PVT),出血和肝脏衰减/ACLF的关联.
- 为了评估FXI在肝硬化患者的预后价值.
主要方法:
- 对183名肝硬化患者进行前性队列研究.
- 测量FXI水平和与临床参数的相关性 (MELD,INR,血小板计数).
- 后勤回归分析以评估与PVT,出血和失补偿的关联,在1年的随访中进行.
主要成果:
- 在肝硬化中,FXI水平降低,随着儿童-普赫阶段的降低 (p < 0.001).
- FXI与MELD得分和INR相反相关,与血小板数相对正相关.
- 血小板计数,而不是FXI,预测PVT (OR:0.94;p < 0.001).
- 没有发现FXI与出血事件或肝缺血/ACLF之间有显著的关联.
结论:
- 在肝硬化中,FXI似乎没有驱动血栓形成或疾病进展.
- 低FXI和出血之间没有联系,这表明FXI抑制剂在这个人群中具有潜在的安全性.
- 对肝硬化患者的FXI抑制剂进行进一步的研究是有必要的.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Coagulation
6.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.2K
Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K


